Sodium mercaptododecaborate (BSH) is a boron cluster compound extensively used in boron chemistry, nuclear medicine, and boron neutron capture therapy (BNCT) research. N-BSH (CAS 144885-51-8) and ¹⁰B-enriched BSH (CAS 12448-24-7) share the same dodecaborate cage structure and mercapto functional group, with the primary difference being their boron isotopic composition and application requirements.
N-BSH contains boron at natural isotopic abundance and is widely applied in early-stage R&D, including synthesis development, formulation optimization, conjugation studies, and preliminary biological evaluation. Its chemical equivalence and cost efficiency make it ideal for screening and method validation.
¹⁰B-enriched BSH features a high concentration of boron-10, which is essential for neutron capture reactions. This material is critical for BNCT studies, radiopharmaceutical research, and advanced preclinical or translational research requiring high neutron capture efficiency.
In practical workflows, researchers typically use N-BSH during early development stages and transition to ¹⁰B-enriched BSH for neutron irradiation and clinically relevant experiments, ensuring both research continuity and cost optimization.
UCHEM maintains ready stock of both N-BSH and ¹⁰B-enriched BSH, enabling fast shipment and short lead times. We support small research quantities to bulk orders, with consistent quality, scalable supply, and flexible packaging options. Complete documentation, including COA and SDS, is available to facilitate rapid project execution and long-term supply planning.
